Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.790
-0.010 (-0.26%)
At close: Sep 18, 2026, 4:00 PM EDT
3.782
-0.008 (-0.21%)
After-hours: Sep 18, 2026, 7:32 PM EDT
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $395.61 million as of September 18, 2026. Its market cap has increased by 13.29% in one year.
Market Cap
395.61M
Enterprise Value
244.30M
1-Year Change
13.29%
Ranking
Category
Stock Price
$3.79
ChartMarket Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $395.61M, an increase of 248.92%. That is a compound annual growth rate of 21.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 395.61M | 21.32% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Artiva Biotherapeutics | 420.94M |
| Inhibikase Therapeutics | 418.77M |
| C4 Therapeutics | 417.06M |
| Editas Medicine | 414.67M |
| ARS Pharmaceuticals | 408.73M |
| Rezolute | 401.15M |
| vTv Therapeutics | 395.11M |
| Galectin Therapeutics | 392.31M |